Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1935 4
1936 2
1937 5
1938 3
1939 1
1941 2
1942 3
1943 5
1944 3
1945 3
1946 9
1947 17
1948 11
1949 11
1950 13
1951 12
1952 7
1953 6
1954 8
1955 5
1956 5
1957 2
1958 2
1959 2
1960 2
1961 4
1962 11
1963 13
1964 13
1965 12
1966 5
1968 4
1970 2
1971 1
1972 2
1973 5
1974 4
1975 6
1976 2
1977 2
1978 6
1979 1
1981 1
1982 2
1983 1
1985 1
1987 1
1988 1
1989 2
1990 2
1991 3
1992 6
1993 4
1994 2
1995 2
1996 2
1997 1
1998 1
1999 3
2000 1
2001 2
2002 5
2003 4
2004 11
2005 15
2006 15
2007 12
2008 23
2009 19
2010 16
2011 24
2012 14
2013 19
2014 23
2015 33
2016 26
2017 24
2018 20
2019 27
2020 28
2021 43
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

656 results
Results by year
Filters applied: . Clear all
Page 1
The evolution of the Escherichia coli phylogeny.
Chaudhuri RR, Henderson IR. Chaudhuri RR, et al. Infect Genet Evol. 2012 Mar;12(2):214-26. doi: 10.1016/j.meegid.2012.01.005. Epub 2012 Jan 14. Infect Genet Evol. 2012. PMID: 22266241 Review.
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma.
Couillard S, Shrimanker R, Chaudhuri R, Mansur AH, McGarvey LP, Heaney LG, Fowler SJ, Bradding P, Pavord ID, Hinks TSC. Couillard S, et al. Among authors: chaudhuri r. Am J Respir Crit Care Med. 2021 Sep 15;204(6):731-734. doi: 10.1164/rccm.202104-1040LE. Am J Respir Crit Care Med. 2021. PMID: 34129808 Free PMC article. No abstract available.
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
Devereux G, Cotton S, Fielding S, McMeekin N, Barnes PJ, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Gompertz S, Haughney J, Innes K, Kaniewska J, Lee A, Morice A, Norrie J, Sullivan A, Wilson A, Price D. Devereux G, et al. Among authors: chaudhuri r. JAMA. 2018 Oct 16;320(15):1548-1559. doi: 10.1001/jama.2018.14432. JAMA. 2018. PMID: 30326124 Free PMC article. Clinical Trial.
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study.
Vijiaratnam N, Girges C, Auld G, Chau M, Maclagan K, King A, Skene S, Chowdhury K, Hibbert S, Morris H, Limousin P, Athauda D, Carroll CB, Hu MT, Silverdale M, Duncan GW, Chaudhuri R, Lo C, Del Din S, Yarnall AJ, Rochester L, Gibson R, Dickson J, Hunter R, Libri V, Foltynie T. Vijiaratnam N, et al. Among authors: chaudhuri r. BMJ Open. 2021 May 28;11(5):e047993. doi: 10.1136/bmjopen-2020-047993. BMJ Open. 2021. PMID: 34049922 Free PMC article.
Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates.
Hoffman NJ, Parker BL, Chaudhuri R, Fisher-Wellman KH, Kleinert M, Humphrey SJ, Yang P, Holliday M, Trefely S, Fazakerley DJ, Stöckli J, Burchfield JG, Jensen TE, Jothi R, Kiens B, Wojtaszewski JF, Richter EA, James DE. Hoffman NJ, et al. Among authors: chaudhuri r. Cell Metab. 2015 Nov 3;22(5):922-35. doi: 10.1016/j.cmet.2015.09.001. Epub 2015 Oct 1. Cell Metab. 2015. PMID: 26437602 Free PMC article.
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Mansur AH, Fowler SJ, Niven RM, Howarth PH, Lordan JL, Menzies-Gow A, Harrison TW, Robinson DS, Holweg CTJ, Matthews JG, Pavord ID; investigators for the MRC Refractory Asthma Stratification Programme. Heaney LG, et al. Among authors: chaudhuri r. Lancet Respir Med. 2021 Jan;9(1):57-68. doi: 10.1016/S2213-2600(20)30397-0. Epub 2020 Sep 8. Lancet Respir Med. 2021. PMID: 32916135 Free PMC article. Clinical Trial.
Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials.
Chaudhuri R, Rubin A, Sumino K, Lapa E Silva JR, Niven R, Siddiqui S, Klooster K, McEvoy C, Shah PL, Simoff M, Khatri S, Barbers R, Mark Grubb G, McMullen EA, Olson JL, Laviolette M; BT10+ Study Group. Chaudhuri R, et al. Lancet Respir Med. 2021 May;9(5):457-466. doi: 10.1016/S2213-2600(20)30408-2. Epub 2021 Jan 29. Lancet Respir Med. 2021. PMID: 33524320 Clinical Trial.
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
McDowell PJ, Diver S, Yang F, Borg C, Busby J, Brown V, Shrimanker R, Cox C, Brightling CE, Chaudhuri R, Pavord ID, Heaney LG; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium). McDowell PJ, et al. Among authors: chaudhuri r. Lancet Respir Med. 2021 Oct;9(10):1174-1184. doi: 10.1016/S2213-2600(21)00004-7. Epub 2021 May 7. Lancet Respir Med. 2021. PMID: 33971168
656 results